Chargement en cours...
Targeting immune checkpoints in malignant glioma
Malignant glioma is the most common and a highly aggressive cancer in the central nervous system (CNS). Cancer immunotherapy, strategies to boost the bodys anti-cancer immune responses instead of directly targeting tumor cells, recently achieved great success in treating several human solid tumors....
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351697/ https://ncbi.nlm.nih.gov/pubmed/27756892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12702 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|